[1] |
LAI Meiyan, LONG Boquan, YE Zhiming, LONG Qi, YANG Lan, YOU Furong, GUO Hongwei.
Primary cutaneous amyloidosis successfully treated with dupilumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(2): 120-122.
|
[2] |
Dilinuer TAXIMAIMAITI, Palida ABULIZI.
Efficacy and safety of abrocitinib and dupilumab in the treatment of moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 533-537.
|
[3] |
HAN Jinghong, LIU Hong.
Two children with refractory atopic dermatitis successfully treated with Janus kinase inhibitors
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 190-192.
|
[4] |
ZHENG Lin, MO You, LI Qian, SI Yuan, SHE Xining, BAI Jingzhu, TANG Yi, LI Qun, FANG Ruihua.
Acquired reactive penetrating collagenosis in patients treated with maintenance hemodialysis: two cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(12): 866-869.
|
[5] |
ZHANG Ruixia, TANG Junting, HE Angran.
Glucocorticoid combined with dupilumab in the treatment of bullous pemphigoid complicated with verruca plana: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(10): 727-729.
|
[6] |
BAI Lu, ZHANG Lijun, ZHU Caiyong.
Update of the treatment for primary cutanious amyloidosis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(10): 744-748.
|
[7] |
ZANG Ying, REN Weiqi, WANG Zihe, WANG Jun.
A case of Netherton syndrome treated with dupilumab and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 9-14.
|
[8] |
JIA Fengming, FANG Meng, LIU Yongxia, LIU Hong.
Dupilumab alone successfully treated an elderly patient with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 661-663.
|
[9] |
DING Gaozhong, LI Shanshan, SUN Lan, WEI Yun.
A case of hypereosinophilic syndrome successfully treated with dupilumab
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 576-579.
|
[10] |
YANG Zijing, PAN Meng, ZHAO Xiaoqing.
Dupilumab-induced immune drifting from atopic dermatitis to polymyalgia rheumatica: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 508-511.
|
[11] |
WANG Tiyan, ZHOU Xiaohong.
Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 413-416.
|
[12] |
SHAO Lifang, TIAN Rong, KONG Weixin, JING Qi, YUAN Xiaoying.
Dupilumab combined with glucocorticoid in the treatment of 4 cases with severe bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(12): 890-893.
|
[13] |
LI Mengmeng, LI Jingyi, LIU Qingfeng, LIU Youqing, LI Wei.
Clinical efficacy and safety of dupilumab in the treatment of moderate and severe atopic dermatitis for 16 weeks
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(12): 849-852.
|
[14] |
JIANG Fei, ZHAO Qing, SUN Yonghu, ZHANG Zhaoxia, YANG Baoqi, YANG Qing, LIU Guoyan, SHI Zhongxiang, LIU Hong, ZHANG Furen.
Efficacy of dupilumab in 5 children with moderate-to-severe atopic dermatitis: a real-world study
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 790-793.
|
[15] |
BAI Lu, ZHU Caiyong.
Update of treatment for annular granuloma
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 842-846.
|